Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong
· Delayed Price · Currency is HKD 40.42
-0.30 (-0.74%)
At close: Dec 5, 2025
Ab&B Bio-Tech CO., LTD. JS Company Description
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vaccine.
The company was founded in 2015 and is based in Taizhou, China.
Ab&B Bio-Tech CO., LTD. JS
| Country | China |
| Founded | 2015 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 583 |
| CEO | Youcai An |
Contact Details
Address: No. 32 Xinglin Road Taizhou, 225300 China | |
| Phone | 86 52 3868 19889 |
| Website | abbbio.com |
Stock Details
| Ticker Symbol | 2627 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000071P9 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Youcai An | GM and Executive Chairman |
| Runxiang Li | Chief Financial Officer and Executive Director |
| Yiming He | Assistant to the Chairman of Board and Executive Director |
| Dr. Ze Chen | Deputy GM and Chief Scientist |
| Yangyang Zhang | Joint Company Secretary |